Ministry: Treatment of patients with favipiravir can start in Hungary

The recent announcement of Japanese clinical trials showing that the generic drug favipiravir is successful in treating Covid-19 patients is reassuring from the point of Hungarian drug development, and it will enable the treatment of patients with the drug to start in Hungary, a ministry of innovation and technology official said.